Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

NCT: NCT04703166 · RECRUITING

NCT IDNCT04703166
StatusRECRUITING
Start Date2025-04-08
Completion2027-12

Brief Summary

To evaluate the progression of atrial myopathy through wearable devices and cardiac imaging.

Frequently Asked Questions

What is Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.?

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy. is a clinical trial registered under NCT04703166. Current status: RECRUITING.

What is the status of NCT04703166?

The current status of NCT04703166 (Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.) is: RECRUITING.

When did Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy. start?

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy. started on 2025-04-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑